Gilead Sciences, Inc. GILD
GILD Rating
GILD Rating Factors
GILD Company Overview
Gilead Sciences, Inc. is a U.S.-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines for life-threatening diseases. The company primarily operates in the biotechnology and pharmaceutical industries, with major therapeutic areas including HIV/AIDS, viral hepatitis, oncology, and inflammatory diseases. Gilead generates most of its revenue from antiviral therapies, particularly HIV treatments, while oncology has become an increasingly important growth area following recent acquisitions and product launches. Its portfolio includes therapies marketed under brands such as Biktarvy, Descovy, Genvoya, Trodelvy, Yescarta, and Veklury.
Gilead was founded in 1987 by Michael L. Riordan and evolved from a small biotechnology research company into one of the largest global antiviral drug developers. The company expanded significantly through internal drug development and acquisitions, including the purchases of Pharmasset in 2011, which strengthened its hepatitis C franchise, and Immunomedics in 2020, which expanded its oncology portfolio. Gilead is widely recognized for its leadership in HIV therapeutics, supported by extensive clinical research capabilities, long-term physician relationships, and a large global commercial infrastructure.
GILD Income Statement
GILD Balance Sheet
GILD Price History
GILD Valuation
GILD Dividends and Shares
GILD Corporate Info
Foster City, CA 94404